Stoke Therapeutics
STOK
#4712
Rank
โ‚ฌ1.68 B
Marketcap
28,48ย โ‚ฌ
Share price
-2.52%
Change (1 day)
312.88%
Change (1 year)

Revenue for Stoke Therapeutics (STOK)

Revenue in 2025 (TTM): โ‚ฌ0.16 Billion

According to Stoke Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.15 Billion. an increase over the revenue in the year 2024 that were of โ‚ฌ35.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Stoke Therapeutics from 2018 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ0.15 B346.9%
2024 โ‚ฌ35.12 M342.24%
2023 โ‚ฌ7.94 M-31.31%
2022 โ‚ฌ11.56 M
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA